High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis
Matthew R. Wilson, Katharine L. Lewis, Amy A. Kirkwood, Kate Cwynarski et autres
1 citationJournal of Clinical Oncology
Nicole Wong Doo
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
83Publications signalées
884Citations signalées
3Affiliations récentes
Institutions déclarées
Domaines associés
Lymphoma Diagnosis and TreatmentMultiple Myeloma Research and TreatmentsChronic Lymphocytic Leukemia ResearchViral-associated cancers and disordersEpigenetics and DNA Methylation
Publications récentes
Historical outcomes for patients with stage IA NLPHL: Global NLPHL One Working Group retrospective analyses
Jamie E. Flerlage, Dennis A. Eichenauer, Michael Fuchs, Sylvia Hartmann et autres
1 citationBlood Advances
Efficacy and Tolerability of Weekly Bortezomib, Lenalidomide, and Dexamethasone Protocols in Transplant‐Ineligible Newly Diagnosed Myeloma: An Australian Real‐World, Multicenter Study
Samantha Kurniawan, Angela Hwang, Nicole Wong Doo, Tracy King et autres
0 citationsAsia-Pacific Journal of Clinical Oncology
Genetically determined body mass index is associated with diffuse large B-cell lymphoma in polygenic and Mendelian randomization analyses.
Demetrius Albanes, Zhaoming Wang, Mark P Purdue, Claire M. Vajdic et autres
0 citationsCarolina Digital Repository (University of North Carolina at Chapel Hill)
Patient reported outcome design, conduct and reporting in australasian leukaemia & lymphoma group (ALLG) cooperative group trials
Arina Martynchyk, Jodie Palmer, Martina Chiarezza, Eliza A. Hawkes et autres
0 citationsBlood
Primary analysis of the phase 3 randomized trial of selinexor and lenalidomide versus lenalidomide alone as maintenance therapy post autologous stem cell transplant for patients with newly diagnosed multiple myeloma (ALLG MM23; SEALAND)
Matthew J. Rees, Masa Lasica, Anna Kalff, Michael Löw et autres
3 citationsBlood
554 Pharmacokinetics (PK) and pharmacodynamics (PD) of ISB 2001, a BCMAxCD38xCD3 trispecific antibody, in TRIgnite-1, the first-in-human (FIH) phase 1 study in relapsed/refractory multiple myeloma (RRMM)
Andrew Garton, Vinu Menon, Hang Quach, Amit Khot et autres
1 citationRegular and Young Investigator Award Abstracts
Genetically determined body mass index is associated with diffuse large B‐cell lymphoma in polygenic and Mendelian randomization analyses
Amy Moore, Eleanor Kane, Lauren R. Teras, Mitchell J. Machiela et autres
0 citationsInternational Journal of Cancer
A Phase I/II Single Arm Study of Belantamab Mafodotin, Carfilzomib and Dexamethasone in Patients with Relapsed Multiple Myeloma (Mm): Primary Analysis. Amarc 19-02 Belacard Study
Masa Lasica, Andrew Spencer, Noemi Horvath, Nicole Wong Doo et autres
0 citationsClinical Lymphoma Myeloma & Leukemia
TRIgnite- 1Study, Phase 1, First-in-Human Study of ISB 2001: A BCMAxCD38xCD3-Targeting Trispecific Antibody for Patients with Relapsed/Refractory Multiple Myeloma (RRMM)—Dose Escalation (DE) Results
Hang Quach, Bradley Augustson, David Levitz, Hanlon Sia et autres
1 citationClinical Lymphoma Myeloma & Leukemia
842 | MYHODGKIN MYHEALTH SURVIVORSHIP APP RECRUITMENT SUGGESTS HIGH ACCEPTABILITY OF PATIENT‐DERIVED DATA IN HODGKIN LYMPHOMA
Nicole Wong Doo, Peter F. Lawrence, G. Klemm, Gajan Kailainathan et autres
1 citationHematological Oncology
23 | RADIOTHERAPY IMPROVES PROGRESSION‐FREE SURVIVAL FOR STAGE IA NLPHL: A RETROSPECTIVE REPORT FROM THE GLOBAL NLPHL ONE WORKING GROUP (GLOW)
Jamie E. Flerlage, Dennis A. Eichenauer, Martina Fuchs, S. Hartmann et autres
1 citationHematological Oncology
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.